Respiratory allergy
The ARISE Trial
Allergic rhinitis (also known as hay fever) affects one in four Australians, but many do not use their treatment nasal spray properly – leading to ongoing symptoms.
The ARISE Trial aims to find out if a specifically designed education package used alongside a daily nasal spray can help reduce symptoms and improve quality of life for young people with the condition.
Overview
Allergic rhinitis (AR) is the most common allergy in the country. However, most people do not seek medical care – and those that do use nasal sprays often don’t use them as consistently or for as long as recommended.
Poor control of symptoms can lead to decreased physical and mental health and underperformance at school and work.
To help improve how young people manage AR, the National Allergy Centre of Excellence (NACE) has launched The ARISE Trial. Participants are randomised into one of two groups.
Researchers will assess whether the specifically designed education package reduces symptoms and improves quality of life, compared to standard care delivered by your doctor.
Group 1: Enhanced Education Package
Participants in this group receive standard education plus a specifically designed patient education toolkit. Weekly reminders will be sent via SMS and email alerts for three months, including links to education resources, correct technique for using your nasal spray, dosing frequency, pollen count updates, relevant information sheets and articles.
Group 2: Standard Education
Participants in this group receive only the standard education usually delivered during the doctor’s appointment and no electronic reminders.
Who can take part:
- 14 to 29 year olds
- People who have doctor-diagnosed hay fever
- Those who have been recommended combination nasal spray for hay fever treatment
What’s involved:
- Complete three short online questionnaires
- Attend three short video calls with the study team
- Follow the educational resources provided
For participants
Do you want to take part in The ARISE Trial to help improve how young people manage hay fever?
For clinicians
The NACE is looking for hospital outpatient, private allergy and GP clinics across Australia to become recruitment sites. To learn more:
Study team
- Professor Connie Katelaris, Chief Investigator
- Associate Professor Joy Lee, Chief Investigator
- NACE Respiratory Allergy Stream Advisory Group
- Danielle West, NACE Clinical Trials Coordinator
- Dr Angela Young, NACE Research Program Manager
Interested in other respiratory allergy studies?
Visit the NACE Allergy Studies Directory for a list of clinical trials, cohort and registry studies recruiting across Australia.
Want to help shape how allergy research is done?
Share your experiences of having allergic rhinitis with researchers, check out the NACE Consumer Engagement Register.
Proudly in partnership with the National Allergy Council and allergy organisations
